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Abstract
Background: Fluorouracil implants are widely used in peritoneal interstitial chemotherapy. Curative effects have
been obtained, but implants have also caused some complications.
Case presentation: We performed an analysis of a 66-year-old male patient’s case history, as well as conventional
pathological analysis and Raman spectroscopic detection of the diaphragmatic tumor. We also analyzed the underlying
causes of this condition to prevent complications and reduce misdiagnoses in future cases. The patient had a history of
peritoneal fluorouracil implantation. Pathological analysis of the diaphragmatic mass revealed foreign particles, and
Raman detection showed that the mass contained fluorouracil.
Conclusion: Fluorouracil implants may persist due to the high concentrations of this drug used in peritoneal
chemotherapy. This finding should provide guidance and improve the application of peritoneal implants. In clinical
trials, and the diagnosis of liver metastasis should be based on pathological results.
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Background
Since the 1990s, carmustine implants have been used for
glioma, and they were approved by the US Food and
Drug Administration (FDA) for marketing in 1996 [1].
In China, the first sustained-release anti-tumor implant
product approved by the CFDA was a polymer carrier
containing 5- fluorouracil components named Sinofuan
(Medicines NO. H20030345, Patent No. 1028685) [2].
Compared with intravenous fluorouracil chemotherapy,
fluorouracil implants such as Sinofuan can improve the
concentration, extend the effective time, and reduce the
toxicity of chemotherapy. Moreover, these implants
allow for targeted effects. Since 2003, fluorouracil implants
have been widely used in peritoneal interstitial chemothe-
rapy for gastric [3], colorectal [4, 5] and ovarian cancers
[6]. They has also been widely used in percutaneous tumor
implants for liver cancer [7]. However, this application has
had significant effects, with related complications including
anastomotic fistula, intestinal obstruction, chemical peri-
tonitis, and wound infection [8]. The case presented here
involves a high concentration of fluorouracil implants that
gathered in the diaphragm, resulting in local tissue necrosis
and fibrous lumps that oppressed the liver.
Case presentation
A 66-year-old male patient was diagnosed with sigmoid
colon cancer by colonoscopy 3 months previously. No
neoadjuvant therapy was done before surgery. The surgery
consisted of sigmoid colon cancer resection performed at
Qilu Hospital of Shandong University. It was an open
operation. When exploring the abdomen, liver and peri-
toneum, no metastatic nodules were found, but a tumor,
about 5 × 3 cm in size, was located in the sigmoid colon.
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The tumor was removed, an anastomosis was done at the
rectum end of the sigmoid colon and plasma muscularis
sutures embedded the anastomosis. 800 mg Sinofuan was
planted in the abdomen for adjuvant chemotherapy, and a
drainage tube was installed to protect the anastomosis.
The operation went smoothly. Postoperatively, the patient
presented abdominal pain, fever, and abdominal fluid. En-
capsulated fluid measuring approximately 6.3 cm × 3.4 cm
was detected in the right upper abdominal cavity, appear-
ing as an echo-free space on ultrasonic screening. After
paracentesis drainage and anti-infection treatment, the
patient’s condition improved and he was discharged. One
month ago, the patient came to our hospital for further
chemotherapy. Physical examination showed no abnorma-
lities. Computed tomography (CT) examination revealed a
right liver lobe lesion of lower density on the eighth
segment, with a diameter of approximately 2.0 cm. On CT
the arterial phase, portal venous phase, and venous phase
showed no obvious enhancement. However, the patient
had normal levels of alpha-fetoprotein (AFP), carcinoem-
bryonic antigen (CEA), cancer antigen 19-9 (CA19-9),
gamma-glutamyltransferase (GGT), and lactate dehydro-
genase (LDH). Before the colon cancer surgery they were
also at normal levels. Combined with the history of colon
cancer surgery and the CT manifestations, this case was
initially diagnosed as liver metastasis. After three rounds
of chemotherapy, CT showed no significant changes
compared with the previous examination. The patient
was then transferred to the surgical ward for further
surgery. During surgery, a 3 cm × 2 cm × 0.7 cm encapsu-
lated white porcelain-like tumor was detected on the
diaphragm oppressing the liver, which caused liver capsule
depression with local shallow sclerosis (see Fig. 1). The
pathological results (see Figs. 2 and 3) showed the dia-
phragmatic surface of the tumor to be highly necrotic,
oozing, and containing cylindrical foreign bodies. In
addition, there was nodular surface hemorrhaging and
necrosis, subcapsular inflammatory cell infiltration, fibro-
sis, and small bile duct hyperplasia.
The Invia confocal Raman microscope by Renishaw
was used to test the remaining foreign bodies in the
diaphragm. A 785-nm wavelength laser was used and
focused by an objective lens with 50X magnification.
The irradiation power was set to 1 %, and the integration
time was 10 s. The collection range of the spectrum was
from 500 to 3200 cm−1. Samples included the cylindrical
foreign body which was embedded in pathological wax
blocks, Sinofuan (Wuhu harbinger of human medicine,
Product lot NO.20130202), and the fluorouracil injection
(HAIPU, Product lot NO.FA140506). WIRE4.0 spectral
software (see Fig. 4) was used for analysis. The three
spectra all showed significant peaks in the areas of
412, 687, 1344, 1538, and 2876 cm−1 of roughly the same
height. Thus, it was concluded that both the cylindrical
Fig. 1 a Arterial phase (09:54:38.31), b Portal venous phase (09:55:03.70), c Venous phase (09:55:42.35), d Diaphragmatic tumor
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foreign body in the pathological wax blocks and Sinofuan
contained fluorouracil.
Discussion
Local recurrence and distant metastasis especially liver
and pulmonary are common in colon cancer. In 50 % of
colorectal cancer patients an increase of CEA is a signal
of recurrence after tumor resection and 15 % of colorec-
tal tumors do not release CEA [9]. In the case described
here, the patient had a history of colon cancer surgery,
and the atypical CT performance for each period of the
liver was due to the low density of the tumor (see Fig. 1).
Tumor markers such as CEA showed no abnormalities
closely associated with the diaphragm, and focal puncture
pathology was not easy to achieve. All these resulted in
misdiagnosis as liver metastasis. Surgery should have been
performed when the tumor appeared as a single and small
mass on CT. But because of the patient’s physical condition
and quality of life, he chose to first have chemotherapy.
In this case, the center of the diaphragmatic mass
showed some white porcelain-like cylindrical particles
(see Fig. 1). The patient had received an 800 mg fluorine
surgical implantation. Based on the surgical, pathological,
foreign body shape, and Raman spectroscopy results
(see Fig. 3), the cylindrical particles were identified as
non-degraded fluorouracil implants.
In clinical practice, abdominal foreign bodies become
fiber-wrapped due to inflammation caused by the forma-
tion of lumps, and misdiagnosis is not uncommon [10].
Items such as legacy gauze [11], surgical sutures [12],
and fish and chicken bones penetrating into the abdo-
minal cavity [13, 14] have formed tumors.
Intraperitoneal chemotherapeutic drugs such as epiru-
bicin, mitomycin, and cisplatin are in the experimental
stage, and there have been no reports of complications
such as in this case. In this case, the foreign body was
aggregated Sinofuan. These implants, which should be
biodegradable, gathered in the diaphragm due to their
high concentration, causing local tissue necrosis and
becoming fiber wrapped to cause liver tumor oppression.
This situation was unlike anastomotic bleeding, abdo-
minal aortic hemorrhage [15], liver granuloma [16], and
other rare complications due to the uneven spread in
surgery. Because of ascites after surgery, Sinofuan gathered
in the diaphragm. Qin ZG et al. [17] conducted expe-
riments in mice using Sinofuan administered intraperito-
neally and found that after a period of implantation,
non-degraded polymers crowded around the liver, the gap
between liver, and stomach and the diaphragm. These
findings reveal that Sinofuan has some risk of spreading
after surgery.
Conclusions
This report demonstrates a new, rare complication of
Sinofuan. Our findings suggest that high-concentration
fluorouracil implants can cause local tissue necrosis and
fiber-wrapped formations. Therefore, the application of
fluorouracil implant surgery must be improved. In par-
ticular, Sinofuan should be used during the preoperative
period under strictly controlled indications [2], such as (1)
in patients at high risk of colorectal cancer recurrence,
especially serious tumor invasion to adjacent tissues. (2)
In those with lymph node metastasis or malignant ascites.
(3) In cases with positive or suspicious peritoneal lavage
cytology, those when high levels of CEA and CK20 mole-
cules in the peritoneal rinse are positive, or when there
is suspicion of micrometastasis. (4) In tumors causing
excessive compression during tumor removal surgery and
cases with ruptured intestines. The contraindications for
fluorouracil implantation include tumor perforation with
Fig. 2 Diaphragmatic tumor (hematoxylin and
eosin, magnification × 100)
Fig. 3 Hepatic nodule (hematoxylin and eosin, magnification × 100)
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peritonitis, intestinal obstruction, severe anemia, hypopro-
teinemia, and abundant ascites [2]. Patients should be
evaluated preoperatively for nutritional status and liver
function. Moreover, these implants should be spread as
evenly as possible or fixed with biological glue. The patient’s
condition should also be carefully monitored, and fluo-
rouracil implants should be avoided in patients prone to
postoperative issues.
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